Clinical trial
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
NCT02857517 is registered in ClinicalTrials.gov with Jiao Mingfei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
- Lead sponsor
- Jiao Mingfei
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2016
- Completion date
- Not reported
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic choroidal neovascularization